Skip to main content
letter
. 2018 May;103(5):e192–e195. doi: 10.3324/haematol.2017.183160

Figure 3.

Figure 3.

The frequencies of patients showing at least one mutation within genes grouped according to their functional properties. The gene groups were: epigenetic regulation (ASXL1, TET2, DNMT3A), splicing (SF3B1, SRSF2, U2AF1), the JAK-STAT pathway (JAK2, CALR, MPL) and the RAS pathway (NRAS, KRAS, CBL).